- $3.32m
- -$5.06m
- $5.37m
Annual balance sheet for Addentax, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1.39 | 18.3 | 18.3 | 17.8 | 12.6 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2.85 | 3.14 | 6.27 | 5.58 | 9.81 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 5.69 | 23 | 29.2 | 29.8 | 22.9 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 7.37 | 0.922 | 20.4 | 19.1 | 0.341 |
| Net Goodwill | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 13.1 | 41.3 | 52.3 | 49.2 | 29.3 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 10.4 | 3.53 | 4.58 | 3.95 | 3.06 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 13.2 | 17.2 | 26.3 | 27.4 | 7.45 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -0.071 | 24.1 | 26 | 21.7 | 21.8 |
| Total Liabilities & Shareholders' Equity | 13.1 | 41.3 | 52.3 | 49.2 | 29.3 |
| Total Common Shares Outstanding |